AIRSUPRA® (albuterol/budesonide) represents a paradigm shift in asthma rescue as the first and only FDA-approved anti-inflammatory rescue inhaler for asthma that is designed to address both ...
Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, suggest adding an inhaled corticosteroid to rescue therapy could sharply reduce ...
WILMINGTON, Del.--(BUSINESS WIRE)--The Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favorable benefit risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results